Corbus Pharmaceuticals Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$44,603,316 over the previous period. Total operating expenses were $13,909,641.
Profit Margin
| 2014 | 0 | -2.54M | |
|---|---|---|---|
| 2015 | 648.38K | -8.85M | -1365.05% |
| 2016 | 1.91M | -19.99M | -1046.27% |
| 2017 | 2.44M | -32.42M | -1328.65% |
| 2018 | 4.82M | -55.67M | -1154.48% |
| 2019 | 36.14M | -69.15M | -191.33% |
| 2020 | 3.93M | -111.30M | -2826.97% |
| 2021 | 881.70K | -45.55M | -5166.42% |
| 2022 | 0 | -55.83M | |
| 2023 | 0 | -44.60M |
0SZI.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 881.70K | 3.93M | 36.14M | 4.82M | 2.44M | 1.91M | 648.38K | 0 |
Cost of revenue | 31.16M | 1.48M | 1.63M | 98.26K | 89.60K | 0 | 26.03M | 0 | 5.88M | 1.25M |
Gross profit | -31.16M | -1.48M | -757.52K | 3.83M | 36.05M | 4.82M | -23.59M | 1.91M | -5.24M | -1.25M |
Operating exp. | ||||||||||
Research and development | 31.16M | 16.13M | 36.44M | 98.26M | 89.60M | 48.61M | 26.03M | 15.43M | 5.88M | 1.25M |
Selling and marketing | -641K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 13.90M | 34.83M | 56.87M | 126.74M | 113.24M | 61.56M | 35.00M | 21.89M | 9.50M | 2.64M |
Operating income | -45.07M | -39.83M | -55.98M | -122.81M | -77.10M | -56.74M | -32.56M | -19.98M | -8.85M | -2.64M |
Other income (expenses), net | 473.98K | -2.51M | 10.34M | 11.54M | 5.65M | 92.79K | 141.20K | -14.09K | 2.95K | 106.68K |
Income before tax | -44.60M | -42.34M | -45.64M | -111.26M | -71.45M | -55.67M | -32.42M | -19.99M | -8.85M | -2.54M |
Income tax expense | 0 | 13.48M | -87.83K | 35.04K | -2.29M | 1.07M | -396.85K | 13.61K | 2.44K | 24.02K |
Net income | -44.60M | -55.83M | -45.55M | -111.30M | -69.15M | -55.67M | -32.42M | -19.99M | -8.85M | -2.54M |
Earnings per share | ||||||||||
Basic EPS | -10.31 | -13.39 | -11.11 | -42.74 | -32.47 | -29.3 | -19.38 | -14.58 | -8.47 | -3.78 |
Diluted EPS | -10.31 | -13.39 | -11.11 | -42.74 | -32.47 | -29.3 | -19.38 | -14.58 | -8.47 | -3.78 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |